The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests

Current Opinion in Hematology

Volumn 11, Issue 5, 2004, Pages 351-356

  Brown, Paul ^a,c   Cervenakova, Larisa ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOLLAND LABORATORY   (United States)

^c NONE   (United States)

Author keywords

Blood infectivity; Blood screening tests; Creutzfeldt Jakob disease; Prion disease; Transmissible spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; IATROGENIC DISEASE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SCRAPIE; SCREENING TEST; SHEEP;

BLOOD DONORS; BLOOD TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IATROGENIC DISEASE; MASS SCREENING;

EID: 13544269543     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moh.0000143393.49202.f0     Document Type: Review

References (37)

1. Hunter N, Foster J, Chong A, et al.: Transmission of prion diseases by blood transfusion. J Gen Virol 2002, 83:2897-2905.
2. Wells GAH, Hawkins SAC, Green RB, et al.: Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 2000, 142:103-106.
3. Taylor DM, Fernie K, Reichel HE, et al.: Infectivity in the blood of mice with a BSE-derived agent [letter]. J Hosp Infect 2000, 46:78-79.
4. Houston F, Foster JD, Chong A, et al.: Transmission of BSE by blood transfusion in sheep. Lancet 2000, 356:999-1000.
5. Bons N, Lehmann S, Mestre-Frances N, et al.: Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 2002, 42:513-516.
6. Brown P, Rohwer RG, Dunstan BC, et al.: The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998, 38:810-816.
7. Brown P, Cervenakova L, McShane LM, et al.: Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood products do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999, 39:1169-1178.
8. Cervenakova L, Yakovleva O, McKenzie C, et al.: Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003, 43:1687-1694.
9. Bruce ME, McConnell I, Will RG, et al.: Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001, 358:208-209.
10. Brown P, Cervenakova L, Diringer H: Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001, 137:5-13. [Published erratum appears in J Lab Clin Med 2001, 137:230.]
11. Brown P, Cervenakova L, Diringer H: Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001, 137:5-13. [Published erratum appears in J Lab Clin Med 2001, 137:230.]
12. Wilson K, Code C, Ricketts M: Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies. BMJ 2000, 321:17-19.
13. Cervenakova L, Brown PW, Hammond DJ, et al.: Factor VIII and transmissible spongiform encephalopathy: the case for safety. Hemophilia 2002, 8:63-75.
14. Ironside JW, Head MW: Variant Creutzfeldt-Jakob disease and its transmission by blood. J Thromb Haemost. 2003, 1:1479-1486.
15. Llewelyn CA, Hewitt RE, Knight RSE, et al.: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004, 363:417-421.
16. Peden AH, Head MW, Ritchie DE, et al.: Autopsy detection of pre-clinical vCJD transmission following blood transfusion from a PRNP codon 129 heterozygote. Lancet 2004, 364:527-529.
17. Smith PG, Cousens SN, d'Huillard Aignaux JN, et al.: The epidemiology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004, 284:161-191.
18. Hilton DA, Ghani AC, Conyers L, et al.: Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004, 203:733-739.
19. McCullough J, Anderson D, Brookie D, et al.: Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion 2004, 44:675-683.
20. McKinley MP, Bolton DC, Prusiner SB: A protease-resistant protein is a structural component of the scrapie prion. Cell 1983, 35:57-62.
21. Shaked GM, Shaked Y, Kariv-Inbal Z, et al.: A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem 2001, 276:31479-31482.
22. Furukawa H, Doh-ura K, Okuwaki R, et al.: A pitfall in diagnosis of human prion diseases using detection pf protease-resistant prion protein in urine. J Biol Chem 2004, 279:23661-23667.
23. Miele G, Manson J, Clinton M: A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med 2001, 7:361-364.
24. Schmerr MJ, Jenny A: A diagnostic test for scrapie-infected sheep using a capillary electrophoresis immunoassay with fluorescent-labeled peptides. Electrophoresis 1998, 19:409-414.
25. Cervenakova L, Brown P, Soukharev S, et al.: Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis 2003, 24:853-859.
26. Safar J, Wille H, Itri V, et al.: Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998, 4:1157-1165.
27. Safar JG, Scott M, Monaghan J, et al.: Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nature Biotech 2002, 20:1147-1150.
28. Bieschke J, Schulz-Schaeffer W, Zerr I, et al.: Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci U S A 2000, 97:5468-5473.
29. Lane A, Stanley CJ, Dealer S, et al.: Polymeric ligands with specificity for aggregated prion protein. Clin Chem 2003, 49:1774-1775.
30. Sano T, Smith CL, Cantor CR: Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science 1992, 258:120-122.
31. Saborio GP, Permanne B, Soto C: Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411:810-813.
32. Deleault NR, Lucassen RW, Supattapone S: RNA molecules stimulate prion protein conversion. Nature 2003, 425:673-674.
33. Zou W-Q, Zheng J, Gray DM, et al.: Antibody to DNA detects scrapie but not normal prion protein. Proc Natl Acad Sci U S A 2004, 101:1380-1385.
34. Zeiler B, Adler V, Kryukov V, et al.: Concentration and removal of prion proteins from biological solutions. Biotechnol Appl Biochem 2003, 37:173-182.
35. Paramithiotis E, Pinard M, Lawton T, et al.: A prion protein epitope selective for the pathologically misfolded conformation. Nat Med 2003, 9:893-899.
36. Cervenakova L, Janiak A, McKenzie C, et al.: Effect of protease treatment on plasma infectivity in variant CJD mice. Transfusion 2004, in press.
37. Sc conformers induced by a synthetic peptide and several prion strains. J Virol 2004, 78:2088-2099.